Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro - Test2 - elhamkhani - TriplyDB

Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro

Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro

http://www.wikidata.org/entity/Q28293679

about

Human breast milk and antiretrovirals dramatically reduce oral HIV-1 transmission in BLT humanized mice The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infection The phospholipid scramblases 1 and 4 are cellular receptors for the secretory leukocyte protease inhibitor and interact with CD4 at the plasma membrane Mucosal HIV transmission and vaccination strategies through oral compared with vaginal and rectal routes Functional domains of the human epididymal protease inhibitor, eppin Antibacterial properties of the sperm-binding proteins and peptides of human epididymis 2 (HE2) family; salt sensitivity, structural dependence and their interaction with outer and cytoplasmic membranes of Escherichia coli Tenascin-C is an innate broad-spectrum, HIV-1-neutralizing protein in breast milk Trichomoniasis and HIV interactions: a review Mycobacterium avium complex augments macrophage HIV-1 production and increases CCR5 expression Anti-inflammatory effects of mutant forms of secretory leukocyte protease inhibitor Innate immune defences in the human endometrium Advances in HIV microbicide development The Role of Cationic Polypeptides in Modulating HIV-1 Infection of the Cervicovaginal Mucosa Alpha-1-antitrypsin interacts with gp41 to block HIV-1 entry into CD4+ T lymphocytes.Secretory Leukocyte Protease Inhibitor Binds to Annexin II, a Cofactor for Macrophage HIV-1 Infection Identification of a novel secretory leukocyte protease inhibitor-binding protein involved in membrane phospholipid movement Structure of the murine secretory leukoprotease inhibitor (Slpi) gene and chromosomal localization of the human and murine SLPI genes Endocrine control of mucosal immunity in the female reproductive tract: impact of environmental disruptors Secretory leukocyte protease inhibitor suppresses the inflammation and joint damage of bacterial cell wall-induced arthritis Increased susceptibility to LPS-induced endotoxin shock in secretory leukoprotease inhibitor (SLPI)-deficient mice Plausibility of HIV-1 Infection of Oral Mucosal Epithelial Cells.Changes in salivary proteome following allogeneic hematopoietic stem cell transplantation.Safety analysis of the diaphragm in combination with lubricant or acidifying microbicide gels: effects on markers of inflammation and innate immunity in cervicovaginal fluid.Chronic hyperbaric exposure activates proinflammatory mediators in humans.Humoral immune responses to HIV in the mucosal secretions and sera of HIV-infected women.Anti-inflammatory and antimicrobial roles of secretory leukocyte protease inhibitor.HIV-Enhancing and HIV-Inhibiting Properties of Cationic Peptides and Proteins.Lipopolysaccharide-related stimuli induce expression of the secretory leukocyte protease inhibitor, a macrophage-derived lipopolysaccharide inhibitor Human immunodeficiency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunity Cathepsin G, a neutrophil-derived serine protease, increases susceptibility of macrophages to acute human immunodeficiency virus type 1 infection A comparative proteomic analysis of the soluble immune factor environment of rectal and oral mucosa.Antiviral activities in human saliva The mouth: a gateway or a trap for HIV?Serpin induced antiviral activity of prostaglandin synthetase-2 against HIV-1 replication Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing.Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cells.Enhanced secretory leukocyte protease inhibitor in human immunodeficiency virus type 1-infected patients Secretory leukocyte protease inhibitor inhibits infection of monocytes and lymphocytes with human immunodeficiency virus type 1 but does not interfere with transcytosis of cell-associated virus across tight epithelial barriers Positive and negative aspects of the human immunodeficiency virus protease: development of inhibitors versus its role in AIDS pathogenesis Oral infectious diseases: a potential risk factor for HIV virus recrudescence?

P2860

Q21131400-393F9800-0D59-4331-B4EA-FCD0E092EBAC Q21134079-DF433ADC-F10F-4F89-9538-8060435CB854 Q21143809-4C805BC4-79CE-494E-A20A-170F23C204A5 Q22241377-3A79C420-45E4-40FC-AC8F-6CBA08E42524 Q24309156-14D6C0FF-0C49-477D-988E-CF8594D691EF Q24529975-58C36C82-9CFB-46BD-AEEE-E79095E5E40D Q24598653-C7B38D8D-E361-4F6F-8F36-B02923185009 Q24630472-C1D34B7A-47F6-4ACB-BE7B-EAF3C372F247 Q24645019-65C7BD02-7F75-4331-A5AD-BCAFB48F8B7A Q24681571-C8DD1F2A-7853-4C09-BD89-B6D7E26A7E29 Q24801159-C5E48E2D-85A0-47F9-ABAF-2821F6D6E4F6 Q26852858-0EF2B0F3-32D8-4EE8-B9B6-FD5C0176CB00 Q27000032-8D6CF3CC-D7F4-4729-BD0F-0008AE48FB6A Q27316160-559619FE-46EC-43D1-B668-B41EF88192C8 Q27485184-E56DFE8C-A406-47FB-9491-F51E4129DFC4 Q28139286-087C550D-876A-479E-A7B4-3DF11570F06C Q28290820-2FCCA501-5A51-4A52-B654-309F2D5C64BB Q28388054-3CE0CF6A-3B1C-4F6F-8D5F-12D394BE2627 Q28572864-266908E7-0EC7-499F-BE8A-A76FA0BCE266 Q28588786-3DA2F475-6D30-43CD-8ACA-FEE6EA5F922B Q30401195-26E45C1A-8806-4DD4-8970-0BA4306ECDF9 Q33270568-D4D4DA54-8AD1-4CEA-86CE-50644CDF3364 Q33399887-304BBE9F-1050-422A-8E48-98F1DCD78A77 Q33425268-F85DC00E-9BB8-4730-B9B9-5142D0803180 Q33624872-CC3975DA-E9A1-41AD-BC85-043138A36022 Q33715960-E6C7D4B4-2053-4E4B-86A9-5F7486E60025 Q33753950-6CD7F2D3-C19D-4E8C-9015-7685B07BEFDC Q33754239-F042C79A-48CD-477A-86F4-26C648628D78 Q33780434-E601EB59-6A44-480A-A55F-39E911B5BDB3 Q33808640-C86ED4F2-84FF-4217-A7CD-82754AF60D48 Q33825756-5066B336-E121-45BA-AADC-E4CDA2D8EF6B Q33856840-A74BE9F4-6065-4033-9ED2-6527A3250AD3 Q33874252-C4F56635-C336-4CE5-A6C1-26206BACD4E5 Q33886860-2EEE10BE-CF35-4ECF-B6A5-54A0538BEA40 Q33920067-FA866A5A-86E4-4EBF-8559-36D849960513 Q33957148-4798581B-2109-411C-B2C3-13C334305EB3 Q33997956-9C7A5C77-A979-47EB-9F38-8CEB4F1A1723 Q33998431-CE89F24C-DC10-43AD-A293-E50323530989 Q34010283-97E066CE-3F5A-4EE2-BA5B-10A873D253E0 Q34038531-9F0D38D9-4A12-4D10-86D0-66F2A3937B78

P2860

Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro

http://www.wikidata.org/entity/Q28293679

description

1995 nî lūn-bûn

@nan

1995 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

1995 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

name

Secretory leukocyte protease i ...... ency virus 1 activity in vitro

@ast

Secretory leukocyte protease i ...... ency virus 1 activity in vitro

@en

Secretory leukocyte protease i ...... ency virus 1 activity in vitro

@nl

type

label

Secretory leukocyte protease i ...... ency virus 1 activity in vitro

@ast

Secretory leukocyte protease i ...... ency virus 1 activity in vitro

@en

Secretory leukocyte protease i ...... ency virus 1 activity in vitro

@nl

prefLabel

Secretory leukocyte protease i ...... ency virus 1 activity in vitro

@ast

Secretory leukocyte protease i ...... ency virus 1 activity in vitro

@en

Secretory leukocyte protease i ...... ency virus 1 activity in vitro

@nl

P1433

Q28293679-1C7328A3-5A17-424F-83BB-584DBCCB1560

P1476

Q28293679-3DBF8B87-39AA-4B7F-A552-C63E281036DD

P2093

Q28293679-18E54E88-F452-4E21-BD64-5FD2FE7514A2

Q28293679-911F164D-6746-4733-83B4-A274B5F65EFA

Q28293679-B93915A8-7FB7-4A1E-88A1-8319B2764C4C

Q28293679-C10B7EEB-C272-4A06-BED6-8BB75CB84C8F

Q28293679-CE66CC2A-FD25-41DC-985E-2D0DEB739396

Q28293679-DC5A86E6-AC67-42C0-9CD1-6C0FDE03ACA2

P2860

Q28293679-053C4D94-E1AA-4D94-BC37-245643758C8C

Q28293679-06BA44F5-DE4B-4CDB-86E7-CB66E07894C2

Q28293679-07B1AB40-263B-4E41-8A10-9F2A79F7502A

Q28293679-084B1579-AD81-45A2-8105-E043F86F1C2C

Q28293679-135BE597-8C58-4A1C-B763-0A9C85DE3FF6

Q28293679-148C037B-B6C7-425A-AD19-0A59136B99D3

Q28293679-2481E9FC-E1F3-4C88-85C0-88B7ED1B42DF

Q28293679-2BD80409-0303-4AF6-B661-64F38F38517C

Q28293679-34F236D0-5E7F-4A13-85E7-503C4FA5223D

Q28293679-37732FFE-4FEF-4187-85E5-395B33546A62

P304

Q28293679-4601F882-63C7-4C23-A477-CD9B7A5D5511

P31

Q28293679-69EEF7C0-1DE0-4E5A-818E-6AFE5102AEA1

P3181

Q28293679-508A3E96-3D4C-483E-A43A-241E84D36A7C

P356

Q28293679-D20EC8F3-2FA1-4E88-9C23-E07993A5B4F9

P407

Q28293679-FC82ECD0-59E9-473D-BA24-443EAAE47B1C

P433

Q28293679-5E6401A2-CEFA-41CA-8696-5EEC60A9B7ED

P478

Q28293679-C53A4995-BCD7-41F9-A09A-A9E28C14CA10

P577

Q28293679-1C79354D-7908-4678-8908-FDAE37F66991

P5875

Q28293679-412F8258-624E-4ED9-8330-BD2487C8328F

P698

Q28293679-C89FB11D-E828-463B-95BD-9D5A6DF9A57F

P932

Q28293679-B7A4AC8D-1A8C-442E-9F2E-D9DF8D41426D

P3181

P356

P1433

Journal of Clinical Investigation

P1476

Secretory leukocyte protease i ...... ency virus 1 activity in vitro

@en

P2093

D J Dripps

http://www.w3.org/2001/XMLSchema#string

J M Orenstein

http://www.w3.org/2001/XMLSchema#string

M Dealy

http://www.w3.org/2001/XMLSchema#string

S M Wahl

http://www.w3.org/2001/XMLSchema#string

S P Eisenberg

http://www.w3.org/2001/XMLSchema#string

T B McNeely

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase

Identification of the U-937 membrane-associated proteinase interacting with the V3 loop of HIV-1 gp120 as cathepsin G

Isolation and sequence of a human gene encoding a potent inhibitor of leukocyte proteases

HIV-1 and its envelope glycoprotein down-regulate chemotactic ligand receptors and chemotactic function of peripheral blood monocytes

HIV in the oral cavity: virus, viral inhibitory activity, and antiviral antibodies: a review

Elastase and cathepsin G of human monocytes. Quantification of cellular content, release in response to stimuli, and heterogeneity in elastase-mediated proteolytic activity

Location of the protease-inhibitory region of secretory leukocyte protease inhibitor

Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and N-acetylcysteine

Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine

Dextran sulfate suppression of viruses in the HIV family: inhibition of virion binding to CD4+ cells

P304

456-64

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1620377

http://www.w3.org/2001/XMLSchema#string

P356

10.1172/JCI118056

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

96

http://www.w3.org/2001/XMLSchema#string

P577

1995-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15582964

http://www.w3.org/2001/XMLSchema#string

P698

7615818

http://www.w3.org/2001/XMLSchema#string

P932

185219

http://www.w3.org/2001/XMLSchema#string